- Acne
- Addiction
- Allergy
- Anti-infectives
- Cardiovascular Disorder
- Dermatological Disorder
- Diabetes
- Dyslipidemia
- Ebola Virus Disease
- Gastrointestinal Disorder
- Headache
- Hepatitis
- Hypertension
- Infection Prevention & Control
- Infections
- Influenza
- Inhalation Devices
- Kidney & Urinary Tract
- Malaria
- Medico-Legal
- Musculoskeletal Disorder
- Neurological Disorder
- Respiratory Tract Disorder
Webcasts
Our Publications
Key Trials
Patient Education
Clinical Tools
Patient Education
Webcasts
Expert's Viewpoint
Our Publications
- Intranasal Steroids for Allergic Rhinitis: A Guide for Practitioners
- Inhalation Devices: Guide for Paramedics
- Allergic Rhinitis- From Beginning to End
- Allergic Rhinitis and Rhinosinusitis: The Link
- Allergy Express: Issue 3
- Bronchonasal Crosstalk
- Nickel Allergies Due to Mobile Phones: Allusion to Practice
- Minimal Persistent Inflammation in Allergic Rhinitis
- ARIA 10' Guidelines Booklet
Patient Education
Webcasts
- Time Series Analysis of Antibiotic Resistance at a Tertiary Care Hospital & Community in Delhi
- Colistin in Carbapenem Resistant Infections Experience from an Indian Centre
- Antibiotic Stewardship – A Must Do in the Era of Antibiotic Resistance (Panel Discussion)
- Judicious Use of Antibiotics
- My Antibiotic Partner for Colistin
Our Publications
Clinical Tools
Webcasts
Expert's Viewpoint
Our Research
Key Trials
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- HOPE 3: Long-term Cholesterol Lowering with Low-dose Rosuvastatin Alleviates CV Risk in Intermediate-Risk Multi-Ethnic Population
- SPRINT: Intensive BP lowering Superior in Terms of Lowering CV Events & Death vs. Standard BP lowering in High-Risk Patients without Diabetes
Patient Education
Guidelines
- ESH/ESC: Management of Arterial Hypertension (2018)
- ESC: Diagnosis and Management of Syncope (2018)
- AHA/ACC/HRS: Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2017)
- ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)
- ADA: Diabetes and Hypertension - Position Statement (2017)
- ACC/AHA/HFSA: Management of Heart Failure-Focused Update of the 2013 Guidelines (2017)
- AACE/ACE: Management of Dyslipidemia and Prevention of Cardiovascular Diseases (2017)
- ACC/AHA/HRS: Evaluation and Management of Patients with Syncope (2017)
- AHA: Meal Timing and Frequency for Prevention of Cardiovascular Diseases-A Scientific Statement (2017)
- ACP/AAFP: Pharmacological Management of Hypertension in Elderly (>60 years) (2017)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- NOF/ASPC: Role of Calcium with or without Vitamin D for the Management of CVD (2016)
- AHA: Impact of Hypertension on Cognitive Function (2016)
- AHA: Sedentary Behavior and Cardiovascular Morbidity and Mortality - A Scientific Advisory (2016)
- Cardiovascular Care in College Athletes - Expert Consensus and Guidelines (2016)
- AHA: Scientific Statement on Drugs that May Cause or Exacerbate Heart Failure (2016)
- USPSTF: Use of Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancers (2016)
- AHA/ASA: Prevention of Stroke in Women (2014)
- Panel of JNC 8: Management of High Blood Pressure (2014)
- ASH/ISH: Clinical Practice Guidelines for the Management of Hypertension (2014)
- AHA: Ambulatory Blood Pressure Monitoring in Children and Adolescents – A Scientific Statement (2014)
- IGH: Indian Guidelines on Hypertension (2013)
- ESC: Management of Cardiovascular Disease during Pregnancy (2011)
- AHA: Prevention of Cardiovascular Disease in Women (2011)
- NICE: Hyperglycemia in Acute Coronary Syndrome (2011)
- ACCF/AHA: Hypertension in the Elderly - Expert Consensus (2011)
- NICE: Clinical Management of Primary Hypertension (2011)
Webcasts
Our Publications
Patient Education
Clinical Tools
Guidelines
- AAD: Highlights of American Academy of Dermatology Recommendation for Management of Acne Vulgaris (2016)
- AAD: Guidelines of Care for Acne Vulgaris Management (2016)
- AAD: Guidelines on Management of Atopic Dermatitis with Topical Therapies (2014)
- IDSA: Practice Guideline for the Diagnosis and Management of Skin and Soft Tissue Infections (2014)
Our Publications
Our Research
Key Trials
- Sustained Reduction in Incident Diabetes Even 3 Years after Withdrawal of Active SMS-based Lifestyle Intervention
- Impact of Diabetes on Kidney Function Decline: Results from A 26-year Follow up of Community-based Cohort
- Preservation of Beta-cell Function: Daily Metformin vs. Intermittent Intensive Insulin Therapy
- Benefits of Initial Combination Therapy of Vildagliptin/Metformin in Asian T2DM Patients
- Impact of Canagliflozin on Cardiovascular and Renal Outcomes in Type-2 Diabetes Patients
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- Prevalence of Diabetes and Prediabetes in 15 States of India: Insights from the ICMR–INDIAB Population-Based Study
- Poorly Controlled Diabetes – Strongest Predictor for Mortality Due to Renal Failure Among Indians: Insights from The Million Death Study
- Early Treatment during Prediabetes Improves Clinical Outcomes and Lowers Healthcare Costs
- Effectiveness and Cost-effectiveness of Benefit-based Treatment vs. Treat-to-target Treatment in Type-2 Diabetes
Patient Education
Clinical Tools
Guidelines
- ADA/EASD: Standards of Medical Care in Diabetes (2019)
- ADA: Evaluation and Management of Youth-onset Diabetes (2018)
- IDF: Management of Diabetic Foot (2017)
- ADA Recommendations: Diabetic Kidney Disease (2017)
- ADA Recommendations: Diagnosis & Management (2017)
- ACP: Oral Pharmacologic Treatment of Type-2 Diabetes Mellitus (2017)
- ADA: Standard of Medical Care in Diabetes (2017)
- NICE: An Update on Diagnosis and Management of Diabetes (Type-1 and Type-2) in Children and Young People (2016)
- CDA: Update to the Pharmacologic Management of Type 2 Diabetes (2016)
- IDF: Management of Diabetes during Ramadan (2016)
- AACE/ACE: Outpatient Glucose Monitoring Consensus Statement (2016)
- NICE: The Diagnosis and Management of Type 1 Diabetes in Adults (2015)
- AHA/ADA: Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus (2015)
- ADA/EASD: Management of Hyperglycemia in Type 2 Diabetes, a Patient-centered Approach: Update to a Position Statement (2015)
- AACE/ACE: Comprehensive Diabetes Management Algorithm (2015)
- ESC: Diabetes, Pre-Diabetes and Cardiovascular Diseases (2013)
- ADA: Nutrition Therapy Recommendations for the Management of Adults with Diabetes: Position Statement (2013)
- NICE: Hyperglycemia in Acute Coronary Syndrome (2011)
- ACSM/ADA: Exercise and Type 2 Diabetes: Joint Position Statement (2010)
-02.jpg)
Webcasts
Our Publications
- The Changing Landscape of CV Risk Reduction - Is LDL Lowering Sufficient: Questions & Answers (Dr. Michael Miller, USA)
- Newer Perspectives in Lipid Management: Questions & Answers (Dr. Harold Bays, USA)
- Newer Perspectives in Statin Therapy: Questions & Answers (Dr. Michael Davidson, USA)
- Atherogenic Dyslipidemia: Questions and Answers (Dr Abhimanyu Garg, USA)
- Dyslipidemia (Essence Series)
Our Research
Key Trials
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- HOPE 3: Long-term Cholesterol Lowering with Low-dose Rosuvastatin Alleviates CV Risk in Intermediate-Risk Multi-Ethnic Population
- ACCORD Eye: Impact of Intensive Treatment Strategies on Progression of Retinopathy in Type-2 Diabetes Mellitus Patients
- ACCORDION: Eye Benefits due to Intensive Glycemic Control Persist even 4 Years after Treatment Discontinuation
- CLARIDI Study (Cholesterol Lowering and Arrhythmia Recurrences after Internal Defibrillator Implantation)
- IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) Study
- ALLIANCE (Analysis of Aggressive Lipid-Lowering Initiation Abates New Cardiac Events)
- TNT (Treating to New Targets) Trial
- CARDS Study (Collaborative Atorvastatin Diabetes Study)
- SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels)
- CAPISH (Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy)
- ROMA (Reduce the Incidence of MyocArdial Periprocedural Necrosis)
Guidelines
- ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA: Management of Blood Cholesterol (2018)
- ACC: Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk-Expert Consensus: Focused Update (2017)
- USPSTF: Use of Statins for the Primary Prevention of Cardiovascular Disease (2016)
- AHA: Management of Clinically Significant Drug Interactions with Statins and Select Agents Used in CVD (2016)
- ESC: Management of Dyslipidemia (2016)
- ACC: Role of Non-Statin Therapy for Lowering LDL-Cholesterol in the Management of Atherosclerotic Cardiovascular Risk-Expert Consensus (2016)
- NICE: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease (2014)
- KDIGO: Lipid Management in Chronic Kidney Disease (2013)
- ACC/AHA: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
- ESC: Management of Dyslipidemias (2011)
- NIH: Detection, Evaluation, and Treatment of High Blood Cholesterol – ATP III (2004)
- NFK KDOQI: Managing Dyslipidemias in Chronic Kidney Disease (2003)
Our Publications
Patient Education
Webcasts
Our Publications
Key Trials
Patient Education
Guidelines
- ACG Guideline: Management of Dyspepsia (2017)
- Maastricht V/Florence Consensus: Management of Helicobacter pylori Infection (2016)
- AGA: Constipation: Medical Position Statement (2014)
- ACG: GERD: Guideline Top Recommendations (2013)
- ACG: Diagnosis and Management of GERD: Guideline Summary (2013)
- WGO: Acute Diarrhea: Practice Guidelines (2012)
- World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD (2010)
- ACG: Ulcerative Colitis: Practice Guidelines (2010)
Our Publications
Conference Proceedings
Patient Education
Guidelines
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- ICSI: Diagnosis and Treatment of Headache (2013)
- International Classification of Headache Disorders (2013)
- IHS: Guideline on Headache Classification (2013)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2012)
- BASH: Guidelines for the Diagnosis and Management of Migraine, Tension-Type headache, Cluster Headache & Medication Overuse Headache (2010)
- EFNS: Guidelines on the Drug Treatment of Migraine: Report (2009)
- SIGNS: Guidelines for the Diagnosis and Management of Headache in Adults (2008)
Our Publications
- Approach to Hepatitis B in Pregnancy
- HCV Management Series: Management of Treatment-naïve and Treatment-experienced HCV Patients
- HCV: Epidemiology, Screening and Diagnosis
- Managing Treatment Response and Resistance in Hepatitis B
- Tenvir (Tenofovir disoproxil fumarate) - Product Monograph
- Practice Guidelines for Chronic Hepatitis B
- Principles of Hepatitis B Treatment
- Evaluating a Patient with Hepatitis B
Key Trials
- Maternal Use of Tenofovir: No Additional Benefit in Lowering Perinatal HBV Transmission
- Sofosbuvir - Velpatasvir FDC for HCV Genotypes 1 to 6 Infection – Integrated Analyses of ASTRAL Studies
- Efficacy of Tenofovir Alone in Hepatitis B Patients with Suboptimal Virologic Response to Adefovir
- Tenofovir Benefits Patients with Severe Reactivation of Hepatitis B
- Tenofovir May be Highly Effective in Chronic Hepatitis B Patients Who Fail to Respond to Lamivudine and Adefovir Therapy
- Entecavir Lowers the Incidence of Hepatocellular Carcinoma in HBV Infected Patients
- Long Term Treatment with Tenofovir Might Result in Regression of Cirrhosis in Patients with Chronic Hepatitis B infection
Conference Proceedings
Patient Education
Guidelines
Webcasts
- Novel and Emerging Treatments for Hypertension
- Highlights of American Society of Hypertension Annual Scientific Meeting, 2015
- Hypertension Update 2014:Focus on New Guidelines
- Insights into JNC 2013 Guidelines, ASH and more...
- Hypertension: Challenges, Dilemmas and New Paradigms
- Recent Trends in Hypertension Management
Our Publications
Our Research
Key Trials
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- Azilsartan is More Effective than Olmesartan in Reducing BP in Hypertensive Patients
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- SPRINT: Intensive BP lowering Superior in Terms of Lowering CV Events & Death vs. Standard BP lowering in High-Risk Patients without Diabetes
- ESPRIT (Efficacy & Safety in Patients with Renal Impairment treated with Telmisartan)
- ROADMAP (Randomized Olmesartan and Diabetes Microalbuminuria Prevention) Study
- PRISMA-II (Prospective, Randomised Investigation of the Safety and Efficacy of Telmisartan Versus Ramipril Using Ambulatory Blood Pressure Monitoring)
- SMOOTH (Study of Micardis in Overweight/Obese patients with Type-2 diabetes and Hypertension)
- PRISMA-I (Prospective, Randomised Investigation of the Safety and Efficacy of Telmisartan Versus Ramipril Using Ambulatory Blood Pressure Monitoring)
- ONTARGET (Ongoing Telmisartan Alone and in Combination with Ramipril Global End-point Trial)
Patient Education
Guidelines
- ESH/ESC: Management of Arterial Hypertension (2018)
- ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)
- ADA: Diabetes and Hypertension - Position Statement (2017)
- ACP/AAFP: Pharmacological Management of Hypertension in Elderly (>60 years) (2017)
- AHA: Impact of Hypertension on Cognitive Function (2016)
- ASH/ISH: Clinical Practice Guidelines for the Management of Hypertension in the Community (2014)
- Panel of JNC 8: Management of High Blood Pressure (2014)
- AHA: Ambulatory Blood Pressure Monitoring in Children and Adolescents – A Scientific Statement (2014)
- API: Indian Guidelines on Hypertension – III (2013)
- ACCF/AHA: Hypertension in the Elderly - Expert Consensus (2011)
- NICE: Clinical Management of Primary Hypertension (2011)
- NFK KDOQI: Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004)
Webcasts
- Judicious use of Antibiotics (2017)
- Common Errors in Antimicrobial Therapy
- Judicious Use of Antibiotics
- Tropical Infections : A Case-based Approach
- Protecting Yourself (and your Patients) from Airborne Pathogens
- Drug Interactions – What Clinicians Need to Know?
- Vaccinations for Adults - What’s New, What Works?
- Pan Resistant Era: An SOS
- Infection Control in Health-Care Facilities: The Current Approach (Panel Discussion)
- If the Last Wall Falls…..The Need for Optimal use of Colistin
- Combating Influenza
- Optimizing the Use of Colistin in MDR Infections
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
- CDC: Guideline for Surgical Site Infection Prevention (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- NCDC: National Risk Communication Plan (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- NCDC/WHO: Indian Public Health Legislations (2015)
- NCDC: National Guidelines on Diagnosis Case Management and Prevention and Control of Leptospirosis (2015)
- WHO: Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV (2015)
- IAP Guidebook on Immunization (2013–2014)
- CDC: Pre-exposure Prophylaxis for the Prevention of HIV Infection – 2014 : A Clinical Practice Guideline (2014)
Webcasts
- Place in Therapy Of I.V Posaconzole In the Management of Invasive fungal infections in High-Risk Patients
- Acute Otitis Media: Case Based Approach
- Urinary Tract Infection in Children : How do I Investigate?
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- Herpetic Keratitis
- Judicious use of Antibiotics (2017)
- Dilemmas in the Management of Invasive Aspergillosis
- Serious Infections and their Mimics: Reading between the Lines
- Sepsis and ARDS: Which is the Chicken and Which is the Egg?
- From Laboratory to Clinic: The Importance of Correlating the Culture Reports with the Clinical Case
- Prevalence, Diagnosis and Management of Differential Fungal Infections
- Tuberculosis Management in the Era of Drug Resistance
- BPH & Comorbidities
- TB: Back with a Vengeance (Panel Discussion)
- My Antibiotic Partner for Colistin
- Fluids in Septic Shock
- The 4 W’s of Antifungals: Why, Whom, Which and When
- Hit Plasmodia Before it Gets Complicated
- Principles and Interpretations of Laboratory Diagnostics for Malaria, Dengue, Typhoid and Tuberculosis
- Lacunae in the Management of TB
- MDR/XDR TB: A Case Based Approach with Panel Discussion
Our Publications
- Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections
- Comprehensive Guide on the Use of Live Attenuated Influenza Vaccine (Nasovac-S)
- Zika Virus: A New Emerging Threat
- Guidance on Risk Categorization of Seasonal Influenza A H1N1 Cases during Screening
- Advisory for Vaccination and other Preventive Measures in Health Care Workers and General Public: Seasonal Influenza A (H1N1)
- Advisory for Families Staying and Travellers Visiting or Returning after Visiting Ebola-affected Countries
- Management of Ebola Virus Disease Patient in a Hospital
- An Overview of the Treatment Approaches Available for Ebola Virus Disease
- Summarized Clinical Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis (Issue 2)
- H1N1 Influenza (Swine Flu) : Clinician's Guide
- H1N1: Guidance for Clinicians & Public Health Professionals
- H1N1: A Swine Flu Pandemic
Key Trials
- Efficacy and Safety of Oral Ciprofloxacin in Management of External Bacterial Otitis
- PROMISE Study: Moxifloxacin, Clinically and Bacteriologically Non-inferior to Ertapenem in Treatment of cIAIs
- OSTRICH: A Short Course of Oral Steroid Treatment not Beneficial over Placebo for Treating Otitis Media with Effusion in Children
- BLISS Study: Continuous Administration of Beta-lactams Associated with Higher Clinical Cure Rates and Better PK/PD Target Attainment Compared to Intermittent Bolus Dosing
- Absence of Pyuria does not Rule out UTI in Children
Patient Education
Clinical Tools
- Patient Screening Questionnaire and Information for Health Care Professionals on Live Attenuated Influenza Vaccine (NASOVAC-S)
- CDC Recommendations for Pregnant Women during Zika Virus Outbreak
- Tracing and Reporting of Contacts for Ebola Virus Disease: Provisional Recommendations
- Ebola Virus Disease: Recommendations on Collection, Storage and Transportation of Samples from Suspected Cases
Guidelines
- AAP: Prevention and Control of influenza in Children (2017-2018)
- ACG Practice Guideline: Evaluation of Abnormal Liver Chemistries (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- WHO: Guidelines for the Treatment of Malaria. Third Edition (2015)
- IAP Guidebook on Immunization (2013–2014)
- IDSA/ ASM: A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases (2013)
- CDC: Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011)
- IDSA: Clinical Practice Guidelines for the Management of Cryptococcal Disease (2010)
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
Webcasts
Our Publications
Key Trials
Webcasts
Our Publications
Our Publications
Patient Education
Guidelines
- ACP: Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: Clinical Practice Guideline (2017)
- ACP: Guidelines for Treatment of Low Bone Density or Osteoporosis in Men and Women (2017)
- EULAR: Recommendations for Early Arthritis Management (2016)
- EULAR/EFORT: Recommendations for Fragility Fracture Management in Patients Older Than 50 Years and Prevention of Subsequent Fractures (2016)
- NOF: Clinician’s Guide for the Management of Osteoporosis (2014)
- NOF: Guidelines on Management of Osteoporosis (2014)
Key Trials
- Long-Term Maternal Use of Acetaminophen during Pregnancy Increases the Risk of ADHD in Offspring
- Vitamin B12 May Reduce the Rate of Brain Volume Loss in Older People without Dementia
- ARIC Study: Migraine with Visual Aura - An Isolated Risk Factor for Cardioembolic Ischemic Stroke in Late-Middle-Aged Individuals
Patient Education
Guidelines
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- ESC: Management of Depression in Coronary Heart Disease Patients-Position Statement (2018)
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke (2018)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- Clinical Practice Guidelines and Principles of Care for People with Dementia (2016)
- NICE: Diagnosis and Management of Depression in Children and Young People (2015)
- AHA/ASA: Guidelines for the Primary Prevention of Stroke (2014)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2012)
Webcasts
- Nebulization: Altogether Better for Acute Asthma (2018)
- Management of Complicated Parapneumonic Effusion: A Physician’s Perspective
- Asthma Diagnosis and Management
- FAQs on Pediatric Asthma
- From Sneeze to Wheeze – A Case Guided Discussion
- Expert Views on GINA Guidelines - Step Wise Approach on Pediatric Asthma
- ARDS - What to Do and What Not to Do?
- Full Support for a Flourishing Asthma Practice
- Good Nebulization Practice (2014)
- Pulmonary Practice for Medicine PGs: Importance, Need & Scope
- Asthma Management: Beyond the Horizon
- Asthma Exacerbation in Children: Re-visiting Basics
- Asthma Management beyond Prescription
- Good Nebulization Practice (2015)
- Asthma Management: What Lies Ahead
- Asthma Diagnosis and Management (in Hindi)
- Improving Outcomes... Earlier the Better in COPD
- Demystifying Nebulization
- Nebulization: Altogether Better for Acute Asthma
- Protecting Yourself (and your Patients) from Airborne Pathogens
- Recurrent Pneumonia - Evaluation and Management
- PURVIEW – Community Acquired Pneumonia
- Approach to Fever with Progressive Respiratory Distress
- Nebulization: Altogether Better for Acute Asthma (Webcast in Hindi)
- Early Intervention in the Clinical Course of COPD - The Sooner the Better
- Managing Refractory Cough
- Helping You Deliver in Your Asthma Practice
- Why Asthma is Good for Your Practice
- Approaching an Elderly Patient with Breathlessness
- Management of Tuberculosis
- PURVIEW - Hospital Acquired Pneumonia
- Approach to Unilateral Pleural Effusion
- How Modern Imaging is Changing Pulmonary Medicine Practice
- PURVIEW - Tuberculosis Updates 2012
- Preparing for Air Travel: Overcoming Problems in Patients with Chronic Respiratory Disease
Expert's Viewpoint
Our Publications
- Flohale (Fluticasone Propionate) 50 mcg Inhaler: Datasheet
- Complementing COPD Management Through Smoking Cessation
- Pulmonary Rehabilitation - An Insight
- Inhaled Drug Delivery Systems
- Severe Asthma: A Clinician’s Guide
- Optimizing Inhaled Drug Delivery – Focus on Spacers
- Optimizing Inhaled Drug Delivery: Focus on Dry Powder Inhalers
- Air Pollution: Should We Care About the Air We Breathe?
- Inhalation Devices: Guide for Paramedics
- Asthma – Answers to Clinical Questions (Volume 2)
- Asthma – Answers to Clinical Questions (Volume 1)
- Nebula - A Refresher for Nurses
- IDSA Clinical Practice Guidelines for Acute Bacterial Rhinosinusitis in Adults
- H1N1: Guidance for Clinicians & Public Health Professionals
Our Research
Key Trials
- Physicians’ Perception on Patterns of Diagnosing and Managing Asthma: A Survey in Myanmar
- Perception of Doctors about Diagnosis, Management and Facing the Challenges with their Patients with Asthma: An Observation-Based Survey in Nepal
- Budesonide–Formoterol More Effective than SABA Alone in Mild Asthmatic Patients
- As-Needed Budesonide–Formoterol Non-inferior to Maintenance Budesonide in Patients with Mild Asthma
- Evaluation of the Demographics, Diagnosis and Monitoring, Management, Device Usage and Adherence Among COPD Patients: A Survey of Doctors in Nepal
- Doctors’ Perception of Diagnosis and Management of Asthma in Malaysia: A Survey of Doctors
- Efficacy and Safety of Moxifloxacin and Gatifloxacin as Initial TB Treatment
- Maintenance and Reliever Therapy with Budesonide/Formoterol Might Reduce the Rate of Severe Exacerbations in Patients with Persistent Asthma
- Real World Clinical Evaluation of Formoterol/Fluticasone Delivered via Revolizer in Persistent Asthma
- AVICA: A Head-to-Head Comparison of Acetaminophen vs. Ibuprofen in Young Children with Mild Persistent Asthma
- CARAS Survey: Co-existence of Allergic Rhinitis and Asthma in Indian Patients
- POSEIDON: Insight into the Reasons for which the Patients Visit Primary Health-Care Practitioners in India
Patient Education
Clinical Tools
Guidelines
- GINA: Asthma Management and Prevention (2019)
- GINA: Asthma Management and Prevention (2018)
- GOLD: Global Strategy for Prevention, Diagnosis and Management of COPD (2018)
- Ministry of Health & Family Welfare: Guidelines for the Management of Seasonal Influenza (Swine Flu) (2017)
- GOLD: A Strategy for The Management of COPD (2017)
- GINA: Global Initiative for Asthma – Global Strategy for Asthma Management and Prevention: Guideline (2017)
- ATS/ACCP: Liberation from Mechanical Ventilation in Critically Ill Adults (2016)
- BTS/SIGN: British Guideline on the Management of Asthma (2016)
- WHO: Updated Treatment Guidelines for Drug-Resistant Tuberculosis (2016)
- GINA: Global Initiative for Asthma – Global Strategy for Asthma Management and Prevention: Guideline (2016)
- NICE: Smoking - Reducing and Preventing Tobacco Use (2015)
- NICE: Smoking – Harm Reduction (2015)
- WHO: Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis (2013)
- NICE: Smoking - Supporting People to Stop (2013)
- IDSA: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis (2012)
- BTS: Guidelines for the Management of Community Acquired Pneumonia in Children (2011)
- WHO: Guidelines for Treatment of Tuberculosis, Fourth Edition (2010)
- WHO: WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households (2009)
- ERS: Defining, Treating and Preventing Hospital Acquired Pneumonia: European Perspective (2009)
- WHO: WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households (2009)
- ATS/ IDSA: An Official ATS/ IDSA Statement: Diagnosis, Treatment and Prevention of Non Tuberculous Mycobacterial Diseases (2007)
- ERS: Smoking Cessation in Patients with Respiratory Diseases: A High Priority, Integral Component of Therapy: Task Force Report (2007)
- ERS: The Assessment of Cough: Guidelines (2007)
- ATS/IDSA: Online Supplement-An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Non Tuberculous Mycobacterial Diseases (2007)
- ATS/IDSA: Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (2005)
